Q2 2026 13F · SEC CIK 1448430

Aldebaran Capital, LLC

Wealth managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $133.1M
Reported positions: 39
Top holdings a year, 3 yrs: +15.1%
Assets under management: $166.9M

Aldebaran Capital, LLC is a wealth manager that reported 39 positions worth $133.1M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Berkshire Hathaway Inc Del (BRK-B, 15.6%), Eli Lilly & Co (LLY, 8.1%), Microsoft Corp (MSFT, 5.6%). A portfolio copying its top holdings returned 15.1% a year over the last 3 years, against 22.3% for the S&P 500.

Aldebaran Capital, LLC holdings all 39 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Aldebaran Capital, LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
BRK-BBerkshire Hathaway Inc Del	15.6%	14.7%	41,508	+3.3%	$20.8M
LLYEli Lilly & Co	8.1%	6.3%	9,007	+0.0%	$10.8M
MSFTMicrosoft Corp	5.6%	5.8%	20,044	-1.5%	$7.5M
BGBunge Global SA	5.3%	6.6%	66,634	-1.4%	$7.1M
IWSIshares Tr	4.9%	4.5%	39,640	-1.2%	$6.5M
OXYOccidental Pete Corp	4.9%	7.7%	133,304	-13.5%	$6.5M
BACBank of Amer Corp	4.4%	3.9%	101,803	-2.3%	$5.8M
SUSuncor Energy Inc New	4.1%	5.2%	102,269	-1.2%	$5.5M
ACRSAclaris Therapeutics Inc	3.7%	2.7%	936,731	-1.1%	$5.0M
GLNCYGlencore PLC	3.4%	3.9%	330,821	-1.3%	$4.5M
CVXChevron Corporation	3.3%	4.2%	26,123	-1.3%	$4.3M
LKQLkq Corp	3.1%	2.3%	157,918	+54.7%	$4.2M
CATOCato Corp New	2.8%	2.5%	1,169,986	-0.6%	$3.8M
JPMJpmorgan Chase & Co	2.8%	2.5%	11,282	+0.0%	$3.7M
AMLXAmylyx Pharmaceuticals Inc	2.6%	2.1%	195,892	-1.0%	$3.5M
SIRISiriusxm Holdings Inc	2.5%	2.0%	114,182	-1.1%	$3.4M
BCIAbrdn Etfs	2.4%	2.7%	141,576	-1.3%	$3.2M
FCXFreeport Mcmoran Inc	2.3%	2.2%	48,219	-1.1%	$3.0M
EWJVIshares Tr	2.2%	0.5%	65,880	+297.7%	$2.9M
MOHMolina Healthcare Inc	2.1%	1.3%	12,491	-0.9%	$2.9M
CENXCentury Alum Co	1.8%	2.6%	51,995	-9.7%	$2.4M
JCOMZiff Davis Inc	1.6%	1.3%	41,172	+0.0%	$2.2M
ENBEnbridge Inc	1.6%	1.6%	39,425	-1.1%	$2.1M
RELLRichardson Electrs Ltd	1.3%	0.8%	93,969	+0.0%	$1.8M
373261056An2 Thereapeutics Inc	1.3%	1.0%	367,435	-1.2%	$1.8M
BRK-ABerkshire Hathaway Inc Del	1.1%	1.1%	2	+0.0%	$1.5M
TECXTectonic Therapeutic Inc	0.9%	0.9%	36,797	-1.0%	$1.3M
PATKPatrick Inds Inc	0.9%	1.2%	13,610	-1.9%	$1.2M
PMVPPmv Pharmaceuticals Inc	0.5%	0.4%	467,432	-1.3%	$626K
MBINMerchants Bancorp Ind	0.4%	0.3%	10,125	+0.0%	$506K
GEGE Aerospace	0.4%	0.3%	1,251	+0.0%	$468K
DUKDuke Energy Corp New	0.3%	0.4%	3,600	+0.0%	$456K
AVIRAtea Pharmaceuticals Inc	0.3%	0.4%	88,180	-2.0%	$410K
GEVGe Vernova Inc	0.3%	0.2%	332	+0.0%	$390K
FFord Mtr Co	0.3%	0.2%	27,500	+0.0%	$382K
HURCHurco Cos Inc	0.2%	0.2%	13,699	-0.2%	$314K
BMOBank of Montreal	0.2%	0.2%	1,700	+0.0%	$300K
OKUROnkure Therapeutics Inc	0.1%	0.1%	39,869	-1.4%	$182K
IMAImagenebio Inc	0.1%	0.1%	18,124	-2.4%	$107K

What Aldebaran Capital, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

No new positions among the largest holdings.

Added to

EWJV Ishares Tr+297.7% shares
LKQ Lkq Corp+54.7% shares

Reduced

OXY Occidental Pete Corp-13.5% shares
CENX Century Alum Co-9.7% shares

Sold out

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year: +25.0% /yr; S&P 500 +11.7%
3 years: +15.1% /yr; S&P 500 +22.3%
5 years: —

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$133.1M	39
Q1 2026	$130.8M	43
Q4 2025	$111.5M	35
Q3 2025	$108.9M	33
Q2 2025	$101.3M	34
Q1 2025	$105.7M	41
Q4 2024	$105.2M	37
Q3 2024	$109.6M	37
Q2 2024	$107.4M	36
Q1 2024	$105.0M	33
Q4 2023	$97.7M	31
Q3 2023	$98.1M	33

Questions about Aldebaran Capital, LLC's portfolio

What stocks does Aldebaran Capital, LLC own?

Aldebaran Capital, LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 39 positions worth $133.1M. The largest are Berkshire Hathaway Inc Del (BRK-B) at 15.6%, Eli Lilly & Co (LLY) at 8.1%, Microsoft Corp (MSFT) at 5.6%, Bunge Global SA (BG) at 5.3% and Ishares Tr (IWS) at 4.9%.

What did Aldebaran Capital, LLC buy last quarter?

In Q2 2026, Aldebaran Capital, LLC added Ishares Tr (EWJV) (+297.7% shares) and Lkq Corp (LKQ) (+54.7% shares), compared with its Q1 2026 filing.

What did Aldebaran Capital, LLC sell last quarter?

In Q2 2026, Aldebaran Capital, LLC sold all of Verizon Communications Inc (VZ), sold all of Kezar Life Sciences Inc (KZR), sold all of Occidental Pete Corp (OXY-WT), sold all of Exxon Mobil Corp (XOM), Occidental Pete Corp (OXY) (-13.5% shares) and Century Alum Co (CENX) (-9.7% shares), compared with its Q1 2026 filing.

How has Aldebaran Capital, LLC's portfolio performed?

A portfolio copying Aldebaran Capital, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +15.1% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +25.0% against +11.7%.

When is Aldebaran Capital, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Aldebaran Capital, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Aldebaran Capital, LLC manage?

Aldebaran Capital, LLC reported $166.9M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $133.1M.